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Summary
Classical congenital muscular dystrophies (CMDs) are
autosomal recessive neuromuscular disorders character-
ized by early onset of hypotonia and weakness, atrophy
of limbs and trunkmuscles, contractures, and dystrophic
changes in the muscle biopsy. So far, only one gene,
LAMA2 (6q2), which encodes the laminin a2 chain (or
merosin), has been identified in these disorders. Muta-
tions in LAMA2 cause CMD with complete or partial
merosin deficiency, detectable by immunocytochemistry
on muscle biopsies, and account for ∼50% of CMD
cases. In a large consanguineous family (11 siblings)
comprising three children affected by CMD without
merosin deficiency, we undertook a genomewide search
by homozygosity mapping and analyzed 380 microsat-
ellite markers. The affected children were homozygous
for several markers on chromosome 1p35-36. We iden-
tified two additional consanguineous families with af-
fected children who also showed linkage to this locus.
A maximum cumulative LOD score of 4.48, at a recom-
bination fraction of .00, was obtained with D1S2885.
A consistent feature in these three families was the pres-
ence of early rigidity of the spine, scoliosis, and reduced
vital capacity, as found in rigid-spine syndrome (RSS).
This study is the first description of a locus for amerosin-
positive CMD and will help to better define the nosology
of RSS.
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Introduction
Congenital muscular dystrophies (CMDs) are a group
of autosomal recessive neuromuscular diseases clinically
characterized by an early onset of hypotonia and weak-
ness, atrophy of limbs and trunk muscles, and multiple
contractures (Banker 1994). Although these diseases are
clinically heterogeneous, their common feature is the
dystrophic pattern of the muscle biopsies, with variation
in muscle-fiber size, necrosis, and increase of the en-
domysial collagen tissue. The first step toward identifi-
cation of the genetic origin of these diseases was the
discovery, in 1993, of the locus (FCMD) implicated in
the Japanese form, known as “Fukuyama CMD” (MIM
253800), on chromosome 9q31 (Toda et al. 1993). This
disease, which is very frequent in Japan, is characterized
by severe hypotonia, mental retardation, and brain
structural abnormalities (Fukuyama et al. 1960). A sec-
ond gene (LAMA2), encoding the laminin a2 chain, also
known as “merosin,” was identified on chromosome
6q2 (Hillaire et al. 1994; Helbling-Leclerc et al. 1995b),
following the discovery that the protein was deficient in
the muscle in biopsies of CMD patients (Tome´ et al.
1994). CMD patients with merosin deficiency (MIM
156225) show mutations in LAMA2 and form a clini-
cally homogeneous group characterized by severe hy-
potonia and muscle weakness and brain white-matter
hypodensity, visualized by magnetic-resonance imaging,
but normal intellectual function (Philpot et al. 1995;
Fardeau et al. 1996). They represent a large proportion
of children affected by classical CMD in whom there is
no severe brain abnormality or mental retardation.
Patients with merosin-positive CMD present hetero-
geneous clinical features, suggesting the involvement of
several gene defects. Attempts have been made to classify
these patients, at the 50th International Workshop of
the European NeuroMuscular Center (ENMC) on Con-
genital Muscular Dystrophy (Dubowitz 1997). They de-
scribed numerous subgroups: (1) CMD clinically close
to merosin deficiency but without white-matter altera-
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tion; (2) rigid-spine syndrome (RSS) characterized by
early contractures of the spine; (3) Ullrich syndrome with
a marked hyperextensibility of distal articulations; and
(4) other cases of CMD, forming a heterogeneous group,
that do not correspond to those described above, some
of which may represent mild forms of muscle-eye-brain
disease or Walker-Warburg syndrome.
In this study we performed the genetic analysis of a
large merosin-positive CMD family with three affected
siblings. Taking advantage of the consanguinity of this
family, we identified, by homozygosity mapping (Lander
and Botstein 1987), a new locus on chromosome 1p35-
36. The analysis of 23 additional consanguineous mer-
osin-positive CMD families led to the identification of
two other families showing linkage to this locus. The
clinical features of these patients were those of CMD
with rigidity of the spine, and it is suggested that this
locus accounts for a proportion of cases classified as
having RSS.
Families and Methods
Family Studies
Twenty-four consanguineous families with at least one
child with a merosin-positive CMD were included in the
study. All the families gave their informed consent. The
diagnosis of CMD was made in accordance with the
criteria proposed by the ENMC on Congenital Muscular
Dystrophy (Dubowitz 1996). The affected individuals of
these families did not have a merosin-deficient CMD, as
determined (1) by the detection, by immuncytochemis-
try, of normal amounts of merosin in the muscle biopsies
of patients; (2) by exclusion of linkage to the LAMA2
gene on 6q2; and (3) by the absence of white-matter
changes, determined by brain imaging. Only patients
with classical CMD (i.e., normal intelligence and no
brain abnormality) were included in this study. The par-
ents were first cousins, in 20 families.
Genotypic Analysis
DNA extraction from blood samples was performed
in accordance with standard procedures (341 Nucleic
Acid Purification, Applied Biosystems). Linkage of the
disease to LAMA2 was excluded for all the patients, by
analysis of microsatellite markers D6S407, D6S1620,
and D6S1705 (Helbling-Leclerc et al. 1995a). For each
member of family 1809, CA-repeat microsatellites from
the Ge´ne´thon human linkage map (Dib et al. 1996) were
analyzed. PCRs were carried out with 80 ng DNA, as
described elsewhere (Vignal et al. 1993). Four PCR prod-
ucts from the same DNA sample, generated with dif-
ferent primer sets, were pooled and comigrated in a sin-
gle line of a 6% polyacrylamide gel. After transfer to
Hybond N (Amersham) membranes, they were hybrid-
ized with a (CA)15 probe labeled by peroxidase and were
detected by chemiluminescence by use of the Enhanced
ChemiLuminescence System (Amersham).
Linkage Analysis
Linkage analysis was performed by use of the
LINKAGE 5.2 package, under the assumptions of au-
tosomal recessive inheritance, an equal recombination
frequency (v) for males and females, a disease-gene fre-
quency of .001, and the following four liability classes:
(0–4 years), (4–8 years), (8–12P  .4 P  .6 P  .8
years), and (112 years). The allele frequenciesP  .95
of the markers linked to the RSS locus were estimated
by analysis of 45 unrelated Moroccan individuals and
45 unrelated Turkish individuals. Two-point LOD scores
were calculated by use of the MLINK program.
Results
Clinical Data
The healthy parents of family 1809 originated from
Morocco and were first cousins. Among their 11 chil-
dren, 3 were affected by merosin-positive CMD (fig. 1).
One girl, III-1, started walking at a normal age but fell
frequently. A sister, III-6, had delays in her early motor
milestones and started walking at 17 mo. They both had
a waddling gait and difficulty in climbing stairs. There
was no subsequent deterioration of their motor ability;
however, they both developed rigidity of the spine, and
the eldest of the two developed scoliosis at 11 years of
age. Their 4-year-old brother, III-9, was hypotonic at
birth and presented a severe and diffuse muscle weakness
and atrophy. He has not been able to walk, so far. The
three children had in common a similar facial weakness,
but there was not any associated swallowing difficulty.
They had a progressive restrictive respiratory syndrome
and nocturnal hypoventilation due to central apneas
during paradoxical sleep, with oxygen desaturation as
low as 70%, as evidenced by a polygraphy sleep study.
Ventilatory support at night was started for the three
children (III-1, III-6, and III-9) at 10, 5, and 3 years of
age, respectively. The biopsies performed on the two girls
(III-1 and III-6), at 5 years and 18 mo of age, respectively,
showed similar changes, characterized by variation in
fiber size, some necrotic fibers, and minimal increase of
interstitial fibrous tissue. These changes were compatible
with a CMD and are referred to as “dystrophic” in table
1. Evoked auditory, visual, and somatoesthesic poten-
tials were normal, and no heart abnormality was de-
tected in these patients. Two other patients, from family
T2 from Turkey and family E1 from Iran, showed similar
features, including rigidity of the spine and respiratory
failure. Their clinical data are summarized in table 1. In
addition, a distant cousin (V-1) of the patient in family
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Figure 1 Pedigrees of three RSS families showing linkage to chromosome 1p. Affected individuals are represented by blackened symbols,
and unaffected individuals are represented by unblackened symbols. Half-blackened symbols with a slash represent deceased subjects who are
thought to have been affected and for whom genetic analysis could not be done. Disease-bearing haplotypes are boxed, for each family.
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Table 1
Clinical Features of Five Patients
FAMILY/PATIENT
1809/III-1 1809/III-6 1809/III-9 T2/IV-2 E1/III-1
Sex Female Female Male Female Male
Age in 1998 (years) 15 7 4 7 13
Age at onset (years) 1 1 Hypotonia at birth Hypotonia at birth Infancy
Age at walking 11 mo 17 mo Never walked 11 mo 2.5 years
Weakness:
Facial muscles     
Shoulder girdle     
Limb muscles     
Foot extensors     
Contractures:
Spine extensors     
Elbow flexors     
Hip extensors     
Pes equinus a    
Creatine kinase Normal Normal Normal Normal Normal
Muscle biopsy (age) Dystrophic
(5 years)
Dystrophic
(18 mo)
Not done Atrophic and hypertro-
phic fibers (3.5 years)
Dystrophic
(10 years)
Vital capacity (age
[years]) 33% (14) 55% (7) Very limited 48% (7) 40% (10)
Age at onset of rigid
spine (years) 7 6  3 5
Age at onset of scolio-
sis (years) 11    10
NOTE.—A minus sign () indicates absence; one plus sign () indicates discrete; two plus signs () indicate moderate; and three plus signs
() indicate severe.
a Surgery at 7 years of age.
T2, who originated from the same village, presented the
same clinical features and died at 16 years of age because
of respiratory failure. Similarly, in family E1, an older
sister (III-2), phenotypically similar to the propositus,
died at 14 years of age because of respiratory failure,
and a female first cousin (III-3) had muscle weakness
and died from an unspecified respiratory illness at 21
years of age.
Linkage Analysis
A genomewide search by homozygosity mapping with
380 polymorphic microsatellite markers, spaced at in-
tervals of ∼10 cM, was undertaken in all the members
of family 1809. Only one marker, D1S470, located on
chromosome 1p35-36, showed the same homozygous
profile in the three affected children, whereas seven of
the eight unaffected siblings were heterozygous. We con-
firmed this positive finding by testing the neighboring
markers (fig. 1). The affected children were homozygous
for the 17 markers analyzed between D1S199 and
D1S496. These markers were studied in 23 other con-
sanguineous merosin-positive CMD families (data not
shown): only two families, T2 and E1, showed linkage
to the locus. The affected children of these families were
homozygous for 13 markers and 11 markers, respec-
tively, which reduced the locus to a 9-cM interval flanked
by D1S2828 and D1S470 (fig. 1). Eight markers gave
significant positive cumulative LOD scores (13), the
highest being 4.48, at , for D1S2885 (table 2).v  .00
In addition, a recombination event that occurred, be-
tween D1S2864 and D1S2698, in the unaffected 13-
year-old individual (IV-1) from family T2 reduced the
locus to a 6-cM interval flanked by D1S2864 and
D1S470. In family 1809, two children, III-5 and III-11,
who had no sign of the disease showed a homozygous
profile for several markers. Since the girl, III-11, is only
1 year old, we cannot exclude the possibility that she
may develop the disease in the future, and, therefore, we
could not exclude from the locus the region between
D1S2698 and D1S234 for which she was homozygous.
However, analysis of the boy, III-5, who was clinically
unaffected at 9 years of age, allowed us to exclude mark-
ers between D1S470 and D1S2749, leading to a 6-cM
locus flanked by D1S2864 and D1S2749 (fig. 2).
Discussion
Linkage data and recombinant analysis allowed us to
find a new CMD locus on chromosome 1p35-36, close
to the Schwartz-Jampel syndrome (SJS) locus (Fontaine
et al. 1996) (fig. 2). Five patients from three CMD fam-
ilies showed linkage to this new locus, and four of them
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Table 2
Cumulative Two-Point LOD Scores for RSS versus Chromosome 1 Markers in Families 1809,
T2, and E1
MARKER
LOD SCORE AT v 
MAXIMUM
LOD
SCORE
MAXIMUM
v.00 .01 .05 .1 .2 .3 .4
D1S199 3.22 1.12 1.76 1.79 1.41 .90 .40 1.81 .07
D1S478 .84 1.71 2.09 1.99 1.50 .93 .39 2.09 .05
D1S2828 1.57 1.21 1.96 2.03 1.64 1.07 .49 2.04 .07
D1S2725 3.80 3.71 3.33 2.86 1.96 1.15 .48 3.80 .00
D1S2864 2.06 2.12 2.12 1.93 1.39 .86 .38 2.15 .03
D1S2698 1.36 1.31 1.10 .87 .47 .22 .08 1.36 .00
D1S482 1.33 1.28 1.07 .83 .46 .21 .08 1.33 .00
D1S458 3.66 3.56 3.17 2.69 1.80 1.03 .42 3.66 .00
D1S2674 3.54 3.46 3.10 2.67 1.83 1.06 .42 3.54 .00
D1S234 3.86 3.75 3.35 2.84 1.89 1.07 .40 3.86 .00
D1S2885 4.48 4.38 3.93 3.37 2.33 1.41 .63 4.48 .00
D1S2749 3.52 3.44 3.11 2.68 1.80 .99 .34 3.52 .00
D1S2787 3.06 3.01 2.75 2.40 1.67 .97 .39 3.06 .00
D1S449 3.68 3.60 3.29 2.87 2.00 1.18 .49 3.68 .00
D1S470 1.17 1.19 1.64 1.61 1.22 .73 .29 1.65 .07
D1S247 .83 1.41 1.86 1.83 1.40 .86 .36 1.88 .07
D1S233 6.20 .96 .20 .52 .59 .43 .21 .60 .15
D1S2830 2.56 .71 1.19 1.22 .98 .64 .30 1.23 .07
D1S496 8.47 .55 .59 .85 .72 .39 .11 .85 .10
Figure 2 Ideogram of chromosome 1p, showing approximate
location of RSS locus. The order of and distances between adjacent
markers are based on the Ge´ne´thon human linkage map (Dib et al.
1996). The markers in boldface are linked to the RSS locus. The lo-
calization of the SJS locus is shown.
had distinctive and similar clinical features. In particular,
they were all ambulant, with a progressive limitation of
the flexion of the neck and trunk, wasting of axial mus-
cles, facial weakness, and respiratory insufficiency re-
quiring nocturnal ventilation support. These clinical fea-
tures resemble those of RSS, first reported by Dubowitz
(1973), which is characterized by a marked limitation
in flexion of the whole dorsolumbar and cervical spine,
owing to contracture of the spinal extensors and leading
to loss of movement of the spine and the thoracic cage.
There may be limitation of other joints, especially a lim-
ited extension of the elbows and the ankles. This con-
dition is not progressive, except for the development of
scoliosis and associated deformities and of respiratory
failure. In the present cases, the scoliosis appeared at
∼10 years of age in the two oldest patients. Subsequently
to the initial description of RSS, the risk that these pa-
tients would develop a restrictive ventilatory syndrome
with nocturnal hypoventilation was documented by sev-
eral studies (Efthimiou et al. 1987; Morita et al. 1990;
Ras et al. 1994). One of the sibs (III-9) in family 1809,
a 4-year-old boy who still was unable to walk, already
had some contracture of the spine extensors, resulting
in a mild hyperextended posture of the neck. Like his
sisters, he developed a respiratory insufficiency requiring
nocturnal mechanical ventilation, at 3 years of age. For
the markers of the locus, this patient presented a ho-
mozygous profile that is the same as that of his sisters,
and, therefore, despite his more severe phenotype, he is
predicted to have inherited the same genetic defect. In-
terestingly, other authors have noted an excess of males
with RSS, suggesting that this syndrome might be an
autosomal recessive disorder with variable penetrance
and sex-linked expression (Mussini et al. 1982). Further
studies will be needed to confirm this possibility.
Among the 24 families analyzed, 2 had children with
typical features of RSS who did not show linkage to
chromosome 1p, suggesting genetic heterogeneity. This
perhaps is not surprising, since a limitation of the flexion
of the spine may develop in several neuromuscular dis-
orders, because of the replacement of the spinal extensor
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muscles by fibrous and adipose tissue, resulting in their
shortening (Poewe et al. 1985; van Munster et al. 1986;
Merlini et al. 1989), and has been described in a variety
of conditions, such as Emery-Dreifuss muscular dystro-
phy (Emery and Dreifuss 1966; Rowland et al. 1979),
neurogenic facio-scapulo-peroneal muscle atrophy (Pal-
mucci et al. 1991), multicore disease (Ben Hamida et al.
1987), vacuolar myopathies (Goto et al. 1981; Bertini
et al. 1986; van Munster et al. 1986), and nemaline
myopathy (Topaloglu et al. 1994). The identification of
the locus reported here may help to better define the
nosology of RSS.
In this study we identified a new locus responsible for
a merosin-positive CMD. The clinical features of the
affected children suggest an overlap with RSS. Since the
increase of connective tissue in muscle biopsy is a com-
mon feature of the CMDs and since the laminin a2 chain
has been identified as the culprit for CMD with merosin
deficiency, extracellular matrix components represent
good candidates for all these disorders. In this respect,
it is interesting to note that there are two extracellular-
matrix genes mapped to chromosome 1p35-36, MFAP2
and HSP2, which encode the microfibril-associated gly-
coprotein and the heparan-sulfate proteoglycan, also
known as “perlecan,” respectively (Kallunki et al. 1991;
Faraco et al. 1995). These proteins are expressed in the
extracellular matrix of different tissues, including skel-
etal muscle, and are potential candidates for this disease.
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